Cargando…
Hemophagocytic Lymphohistiocytosis Following BNT162b2 mRNA COVID-19 Vaccination
Although serious adverse events have remained uncommon, cases of myocarditis induced by messenger RNA (mRNA) COVID-19 vaccines have been reported. Here, we presented a rare but potentially fatal disorder, hemophagocytic lymphohistiocytosis, in a 14-year-old previously healthy adolescent after BNT162...
Autores principales: | Lin, Ting-Yu, Yeh, Yun-Hsuan, Chen, Li-Wen, Cheng, Chao-Neng, Chang, Chen, Roan, Jun-Neng, Shen, Ching-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025976/ https://www.ncbi.nlm.nih.gov/pubmed/35455321 http://dx.doi.org/10.3390/vaccines10040573 |
Ejemplares similares
-
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination
por: Caocci, Giovanni, et al.
Publicado: (2021) -
A case of hemophagocytic lymphohistiocytosis after BNT162b2 COVID-19 (Comirnaty®) vaccination
por: Shimada, Yoshitaka, et al.
Publicado: (2022) -
Hemophagocytic Lymphohistiocytosis in Dermatomyositis
por: Liao, Hsien-Tzung, et al.
Publicado: (2019) -
Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021) -
Safety and BNT162b2 mRNA COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2021)